Emil Lou, Professor with Tenure at University of Minnesota, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Strong work from this budding Pancreatic Cancer Genomics Consortium led by Dr. Brett Ecker at Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Published online in Annals of Surgery October 2025: Original Study”
Title: SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer: A Multicenter, Retrospective Cohort Study.
Authors: Julia Button, Elishama Kanu, Ethan Agritelley, Erin M. Dickey, Brian Diskin, Akshat Sarkari, Unaiza Zaman, Rajalaxmi Sharanappa, Annie Kim, Vanessa Marin-Guerra, David G. Brauer, Jashodeep Datta, Brock Hewitt, Michael E. Lidsky, Emil Lou, Nipun Merchant, Daniel Nussbaum, Susanna Ulahannan, Caitlin Hester, Brett L. Ecker
Read the Full Article on Annals of Surgery
More posts featuring Emil Lou.